X 
Board Meetings
Home | Market Info | Company Profile | Board Meetings
Shreekrishna Biotech Ltd.
BSE CODE: 505592   |   NSE CODE: NA   |   ISIN CODE : INE571N01015   |   12-Aug-2015 Hrs IST
BSE NSE
Rs. 141.40
0 ( 0% )
 
Prev Close ( Rs.)
141.40
Open ( Rs.)
141.40
 
High ( Rs.)
141.40
Low ( Rs.)
141.40
 
Volume
1
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
Source DateBoard Meeting DateDetails
24-Jul-2018 04-Aug-2018 The trading window will remain closed from July 25, 2018 to August 04, 2018 (both days Inclusive) in connection with the announcement of the Un-audited financial results of the company for quarter ending June 30, 2018 for Directors and other employees of the Company covered under the Code. The trading window will reopen on August 08, 2018.
29-Jan-2018 10-Feb-2018 the meeting of the Board of Directors of the Company will be held on Saturday, February 10, 2018, inter alia, to consider the Un-audited financial results of the company for quarter ending December 31, 2017.
31-Oct-2017 13-Nov-2017 the meeting of the Board of Directors of the Company will be held on Monday, November 13, 2017, inter alia, to consider the Un-audited financial results of the company for quarter ending September 30, 2017.
25-Jul-2017 03-Aug-2017 Quarterly Results
01-Feb-2017 13-Feb-2017 Quarterly Results
19-May-2016 28-May-2016 Audited Results
25-Jul-2013 31-Jul-2013 to transact the following business: 1. To consider the appointment of new director. 2. To consider the option for increase of Authorized Capital of the Company, subject to consent of the members of the Company. 3. To raise fund by offering, issuing and allotting convertible warrants on preferential basis, subject to consent of the members of the Company. 4. To authorize any of the Director of the Company to issue notice calling the Extra Ordinary General Meeting of the members of the Company.
20-Mar-2013 26-Mar-2013 to transact the following business: 1. To consider the appointment of new director. 2. To consider the option for increase of Authorized Capital of the Company, subject to consent of the members of the Company. 3. To raise fund by offering, issuing and allotting convertible warrants on preferential basis, subject to consent of the members of the Company. 4. To authorize any of the Director of the Company to issue notice calling the Extra Ordinary General Meeting of the members of the Company.
20-Jan-2004 28-Jan-2004 Quarterly Results
02-Dec-2003 05-Dec-2003 Accounts
Page 1 of 2
PREV || NEXT